Meaning
Analytical variance between independent laboratory tests measures the magnitude of chemical composition disagreement during commercial raw material settlements. An assay discrepancy occurs when buyer and seller laboratory results for valuable or deleterious element concentrations fall outside contractually agreed splitting limits. Moisture loss during sample transport, segregation of heavy minerals, and calibration drifts in spectroscopy equipment drive differences between exchange certificates.
Primary governance covers commercial lot sampling protocols, leaving technical measurement errors to standard laboratory audit procedures. Application ceases once parties execute final settlement documentation or submit samples for binding umpire arbitration.
Variance Origin
Sampling procedures introduce systemic error when bulk materials contain heterogeneous mineral distributions. An assay discrepancy frequently originates during primary sample splitting rather than final instrumentation analysis. Subsampling coarse concentrates without proper size reduction concentrates dense metallic particles in specific fractions, creating biased test portions.
Duplicate composite samples sent to facility laboratories exhibit variance when sample moisture changes during storage. Temperature fluctuations during drying cycles further alter reported dry-weight metal contents.
Settlement Procedure
Commercial contracts specify explicit tolerance bands within which exchange samples are averaged to establish final invoice pricing. When an assay discrepancy exceeds the contractual splitting limit, a sealed reserve sample travels to an agreed independent umpire laboratory. The umpire result determines settlement according to defined contractual rules.
If the umpire value falls between buyer and seller figures, the final price adjusts to the umpire result. When the value falls outside the exchange range, the party closest to the umpire value wins the settlement.
Financial Exposure
Unresolved variance in reported metal content directly shifts working capital requirements during concentrate trading. Timely resolution of assay discrepancy eliminates open invoice adjustments and stabilizes cash flow projections across bulk shipment schedules.